These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 14724308)

  • 21. Emerging treatment of acute coronary syndromes with platelet glycoprotein IIB/IIIA inhibitors.
    Roe MT; Moliterno DJ
    J Thromb Thrombolysis; 1999 Jun; 7(3):247-57. PubMed ID: 10373718
    [No Abstract]   [Full Text] [Related]  

  • 22. [Monoclonal antibodies in cardiology].
    Legrand V
    Rev Med Liege; 2009; 64(5-6):310-2. PubMed ID: 19642465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycoprotein IIb/IIIa inhibitors improve outcome after coronary stenting in clopidogrel nonresponders: a prospective, randomized study.
    Cuisset T; Frere C; Quilici J; Morange PE; Mouret JP; Bali L; Moro PJ; Lambert M; Alessi MC; Bonnet JL
    JACC Cardiovasc Interv; 2008 Dec; 1(6):649-53. PubMed ID: 19463379
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
    Parmar R; Stouffer GA
    Am J Med Sci; 1997 Jul; 314(1):31-6. PubMed ID: 9216438
    [No Abstract]   [Full Text] [Related]  

  • 25. Blocking platelets more: are we skating on thin ice?
    Choussat R; Montalescot G
    Heart; 1998 Jan; 79(1):5-6. PubMed ID: 9505907
    [No Abstract]   [Full Text] [Related]  

  • 26. Future trials of antiplatelet agents in cardiac ischemia.
    Throckmorton DC
    N Engl J Med; 2001 Jun; 344(25):1937-9. PubMed ID: 11419432
    [No Abstract]   [Full Text] [Related]  

  • 27. [Antithrombotic treatment of acute coronary syndromes without ST-segment elevation].
    Radke PW; Schunkert H
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S204-7. PubMed ID: 17109249
    [No Abstract]   [Full Text] [Related]  

  • 28. Aspirin beyond platelet inhibition.
    Verheugt FW; Gersh BJ
    Am J Cardiol; 2002 Jul; 90(1):39-41. PubMed ID: 12088777
    [No Abstract]   [Full Text] [Related]  

  • 29. Clopidogrel under scrutiny.
    Satler LF
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):925-6. PubMed ID: 19016464
    [No Abstract]   [Full Text] [Related]  

  • 30. In the era of stabilize and seal, is there a role for GP IIb/IIIa agents in PCI?
    Gilchrist IC
    Catheter Cardiovasc Interv; 2010 May; 75(6):903-4. PubMed ID: 20432396
    [No Abstract]   [Full Text] [Related]  

  • 31. Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators.
    Lincoff AM; Califf RM; Moliterno DJ; Ellis SG; Ducas J; Kramer JH; Kleiman NS; Cohen EA; Booth JE; Sapp SK; Cabot CF; Topol EJ
    N Engl J Med; 1999 Jul; 341(5):319-27. PubMed ID: 10423466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Platelet glycoprotein IIb/IIIa receptor blockade after coronary angioplasty.
    Gambassi G; Landolfi R; Bernabei R
    N Engl J Med; 1997 Oct; 337(17):1243-4. PubMed ID: 9340528
    [No Abstract]   [Full Text] [Related]  

  • 33. Does pre-treatment with aspirin and loading dose clopidogrel obviate the need for glycoprotein IIb/IIIa antagonists during elective coronary stenting? A focus on peri-procedural myonecrosis.
    Claeys MJ; Van der Planken MG; Bosmans JM; Michiels JJ; Vertessen F; Van Der Goten P; Wuyts FL; Vrints CJ
    Eur Heart J; 2005 Mar; 26(6):567-75. PubMed ID: 15618034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).
    Braunwald E; Antman EM; Beasley JW; Califf RM; Cheitlin MD; Hochman JS; Jones RH; Kereiakes D; Kupersmith J; Levin TN; Pepine CJ; Schaeffer JW; Smith EE; Steward DE; Theroux P; Gibbons RJ; Alpert JS; Faxon DP; Fuster V; Gregoratos G; Hiratzka LF; Jacobs AK; Smith SC;
    Circulation; 2002 Oct; 106(14):1893-900. PubMed ID: 12356647
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of angioplasty with stenting in acute myocardial infarction.
    Herrmann HC
    N Engl J Med; 2002 Aug; 347(5):367-8; author reply 367-8. PubMed ID: 12151478
    [No Abstract]   [Full Text] [Related]  

  • 36. [Impact of GP IIb/IIIa antagonists in interventional cardiology].
    Scheller B; Hennen B; Böhm M; Nickenig G
    Dtsch Med Wochenschr; 2003 Feb; 128(6):281-7. PubMed ID: 12571800
    [No Abstract]   [Full Text] [Related]  

  • 37. [New antiaggregants and their importance for the practitioner].
    Tsakiris DA
    Ther Umsch; 2003 Jan; 60(1):24-6. PubMed ID: 12638474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Introduction: glycoprotein IIb/IIIa blockers in the era of metallic coronaries.
    Goldschmidt-Clermont PJ
    J Invasive Cardiol; 2002 Dec; 14 Suppl E():1E. PubMed ID: 12668856
    [No Abstract]   [Full Text] [Related]  

  • 39. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
    Exaire JE; Fathi RB; Brener SJ; Karha J; Ellis SG; Bhatt DL
    Arch Cardiol Mex; 2006; 76(4):376-82. PubMed ID: 17315613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials.
    van de Werf F
    Eur Heart J; 1996 Mar; 17(3):325-6. PubMed ID: 8737200
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.